This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
Summary
- Always check the needle hub for signs of damage or leakage after attaching the needle to the syringe using a gentle twisting motion. A cracked needle hub can result in leakage of the medication and incomplete administration of the dose.1
- Slowly inject the entire contents of the syringe intramuscularly, deep into the selected upper-outer quadrant of the gluteal muscle of the patient. Do not administer by any other route.1
- Administration of INVEGA HAFYERA should be in a single injection. Do not administer the dose in divided injections.1
- Future injections should be alternated between the two gluteal muscles.1
- No clinical data are available on administering partial or divided doses of INVEGA HAFYERA.
LITERATURE SEARCH
A literature search of MEDLINE®, EMBASE®, BIOSIS Previews®, and DERWENT Drug File (and/or other resources, including internal/external databases) pertaining to this topic was conducted on 14 April 2024.
1 | Data on File. Paliperidone palmitate 6-month injection. Version 003. Janssen Research & Development, LLC. Paliperidone Palmitate CCDS; 2022. |